UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.170

Sortiert nach

Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies

Leukemia, 2016-12, Vol.30 (12), p.2364-2372

2016

Volltextzugriff (PDF)

The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells

Leukemia, 2012-12, Vol.26 (12), p.2554-2557

2012

Volltextzugriff (PDF)

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

Leukemia, 2007-05, Vol.21 (5), p.956-964

2007

Volltextzugriff (PDF)

Circulating miRNA markers show promise as new prognosticators for multiple myeloma

Leukemia, 2014-09, Vol.28 (9), p.1922-1926

2014

Volltextzugriff (PDF)

Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells

Cell death and differentiation, 2012-03, Vol.19 (3), p.523-533

2012

Volltextzugriff (PDF)

Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness

Annals of oncology, 2012-09, Vol.23 (9), p.2356-2362

2012

Volltextzugriff (PDF)

Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells

Leukemia, 2014-05, Vol.28 (5), p.1158-1163

2014

Volltextzugriff (PDF)

The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model

Leukemia, 2014-07, Vol.28 (7), p.1501-1510

2014

Volltextzugriff (PDF)

Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse

Leukemia, 2012-07, Vol.26 (7), p.1698-1701

2012

Volltextzugriff (PDF)

Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma

Bone marrow transplantation (Basingstoke), 2015-10, Vol.50 (10), p.1379-1381

2015

Volltextzugriff (PDF)

Evaluating Pekin duck walking ability using a treadmill performance test

Poultry science, 2016-10, Vol.95 (10), p.2244-2249

2016

Volltextzugriff (PDF)

XmAb-5574 antibody demonstrates superior antibody-dependent cellular cytotoxicity as compared with CD52- and CD20-targeted antibodies in adult acute lymphoblastic leukemia cells

Leukemia, 2012-07, Vol.26 (7), p.1720-1722

2012

Volltextzugriff (PDF)

Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol

Leukemia, 2011-09, Vol.25 (9), p.1444-1451

2011

Volltextzugriff (PDF)

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL

Leukemia, 2018-01, Vol.32 (1), p.83-91

2018

Volltextzugriff (PDF)

Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism

Leukemia, 2006-02, Vol.20 (2), p.272-279

2006

Volltextzugriff (PDF)

Serious pulmonary toxicity in patients with Hodgkin’s lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism

Annals of oncology, 2010-11, Vol.21 (11), p.2246-2254

2010

Volltextzugriff (PDF)

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)

Blood, 2003-01, Vol.101 (1), p.6-14

2003

Volltextzugriff (PDF)

Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia

Oncogene, 2007-05, Vol.26 (25), p.3644-3653

2007

Volltextzugriff (PDF)

Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3)

Leukemia, 2016-07, Vol.30 (7), p.1586-1589

2016

Volltextzugriff (PDF)

Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1800-1816

1995

Volltextzugriff (PDF)

Rituximab Using A Thrice Weekly Dosing Schedule in B-Cell Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Demonstrates Clinical Activity and Acceptable Toxicity

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2153-2164

2001

Volltextzugriff (PDF)

The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells

Leukemia, 2004-07, Vol.18 (7), p.1207-1214

2004

Volltextzugriff (PDF)

Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia

Leukemia, 2010-01, Vol.24 (1), p.97-104

2010

Volltextzugriff (PDF)

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia

Leukemia, 2017-10, Vol.31 (10), p.2211-2218

2017

Volltextzugriff (PDF)

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid Leukemia varies by cytogenetic subtype

Cancer research (Chicago, Ill.), 1998-09, Vol.58 (18), p.4173-4179

1998

Volltextzugriff (PDF)

1 – 25 von 2.170

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.925)
Mit Volltextzugriff
(1.928)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(2.146)
Japanisch
(220)
Französisch
(18)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.158)
Life Sciences & Biomedicine
(1.003)
Humans
(889)
Female
(466)
Male
(442)
Biological And Medical Sciences
(424)
Medical Sciences
(341)
Adult
(314)
Middle Aged
(301)
Animals
(274)
Aged
(259)
Oncology
(253)
Hematology
(223)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(151)
Physical Sciences
(133)
Mice
(118)
Aged, 80 And Over
(117)
Leukemia
(113)
Hematologic And Hematopoietic Diseases
(102)
Chronic Lymphocytic Leukemia
(99)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(312)
Journal Of Clinical Oncology
(98)
Leukemia
(53)
Cancer Research
(48)
The Faseb Journal
(46)
Physical Review. C, Nuclear Physics
(44)
Journal Of The Academy Of Nutrition And Dietetics
(35)
Poultry Science
(32)
Physical Review Letters
(25)
Blood Advances
(21)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies

The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

Circulating miRNA markers show promise as new prognosticators for multiple myeloma

Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells

Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness

Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells

The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model

Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse

Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma

Evaluating Pekin duck walking ability using a treadmill performance test

XmAb-5574 antibody demonstrates superior antibody-dependent cellular cytotoxicity as compared with CD52- and CD20-targeted antibodies in adult acute lymphoblastic leukemia cells

Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL

Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism

Serious pulmonary toxicity in patients with Hodgkin’s lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)

Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia

Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3)

Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review

Rituximab Using A Thrice Weekly Dosing Schedule in B-Cell Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Demonstrates Clinical Activity and Acceptable Toxicity

The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells

Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid Leukemia varies by cytogenetic subtype

Suchergebnisse filtern